Report of Analysis
Client / Product Manufacturer
Authorized Clinical & Research Formulation Partner • Frankfurt am Main, Germany
Sample received: 08/12/26
Analysis conducted: 08/13/26
Certificate ID: BK-COA-898938
Batch / Lot: LOT-2026-174
Product: Dormexa™ (DSIP 12 mg) ↗
Appearance: Sterile lyophilized cake in borosilicate vial
Qualitative and quantitative chemical analysis by RP-HPLC with UV detection
Results
Identity: Dormexa™ (DSIP 12 mg)
Quantity: 12.384mg
Purity: 99.694%
DAD1 A, Sig=220,4 Ref=off
CHROMATE HPLC 300 250 200 150 100 0 mAU 5 10 15 20 min 16.890 min MAIN PEAK Area: 99.694%
Dormexa™ (DSIP 12 mg)
Tested Batch Vial